companydata.dkcompanydata.dk

HEMO Invest ApS: Financial statements 2025

CVR: 38403125

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

HEMO Invest ApS (CVR 38403125) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -31,106 and a net result of DKK 527,412 compared with DKK 2,192,878 the year before. Equity in the 2025 report amounted to DKK 29,897,046. The solvency ratio was 99.7%. The company had 1 employee in the financial year.

Gross Profit
DKK -31,106
Profit/Loss
DKK 527,412
Equity
DKK 29,897,046
Total Assets
DKK 29,975,197
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--31K527K29.9M1
2024--35K2.2M29.9M1
2023--62K1.5M28.3M1
2022--29K-3.1M27.6M-
2021--55K17.2M30.8M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is HEMO Invest ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

HEMO Invest ApS: The 2024 annual report is outFeb 16, 2025

HEMO Invest ApS has published its annual report for 2024. Gross profit came to DKK -34,923, and the net result was DKK 2,192,878.

About HEMO Invest ApS

HEMO Invest ApS is a Danish company of the type Anpartsselskab based in Juelsminde, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Henrik Mortensen. The company is owned by Henrik Mortensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -31,106 and a net result of DKK 527,412 compared with DKK 2,192,878 the year before. Equity in the 2025 report amounted to DKK 29,897,046.

Source: annual report 2025, Danish Business Authority